Looking for a tirzepatide injection near you? Here's what the evidence says

SURMOUNT-1 showed what tirzepatide can do, here's why the supply route shapes that outcome

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity across 72 weeks. Those on the highest tirzepatide dose lost around 20–21% of their body weight on average. Those results were achieved inside a closely supervised clinical programme, regular reviews, dose titrations at the right intervals, and consistent use of a genuine, properly stored medicine. The supply route is part of the result. A pen that has been stored incorrectly, sourced without clinical oversight, or obtained from an unverified seller cannot replicate those conditions. The MHRA has seized approximately 20 million doses (~£45m street value) of illegally traded weight-loss medicines and raided the UK's first illicit site producing counterfeit tirzepatide pens. Some fake pens have contained insulin. Searching for the cheapest or most convenient option is understandable, but for a prescription medicine, the safer question is: who is reviewing my case, and where is this pen coming from?

If you're feeling a bit frustrated by how complicated this seems, you're not alone. A lot of people come to us after weeks of confusing searches. The answer really is simpler than it looks: a regulated online pharmacy with a GPhC-registered Independent Prescriber can do everything a local clinic does, faster, with your pen arriving the next working day. You can verify any online pharmacy on the GPhC register before you hand over any details.

Who the UK licence covers (and what a prescriber weighs up

Tirzepatide is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above if at least one weight-related condition is present) for example, high blood pressure, high cholesterol, type 2 diabetes, prediabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. NICE's TA1026 recommends tirzepatide for adults with a BMI of 35 or above plus at least one weight-related comorbidity when accessed through NHS commissioning, though the private licensed criteria are broader.

A BMI figure alone does not guarantee a prescription. When a prescriber reviews your consultation, they are looking at your full picture: current medicines, medical history, any contraindications (including a history of pancreatitis or medullary thyroid carcinoma), and whether the benefit outweighs the risk for you specifically. Pregnancy, breastfeeding and trying to conceive are situations where tirzepatide is not recommended; the treatment is also not licensed for under-18s. If you want to understand what the prescriber is weighing up before you start, our FAQs page covers the most common eligibility questions in plain language. For a fuller picture of how the medicine itself works, the Mounjaro overview page is a good starting point.

Injecting tirzepatide correctly: what makes the difference

Once a prescription is in place, technique becomes the practical priority. Tirzepatide is injected subcutaneously, the needle goes into a small pinch of skin, not into muscle. The three recommended sites are the abdomen, the front of the thigh and the outer upper arm. Rotating between sites each week reduces the chance of localised skin reactions. The KwikPen is designed to make this straightforward: you dial, press and hold. That said, the first injection often feels daunting. Our step-by-step guide to injecting tirzepatide walks through the process in plain detail, including what to do if you see air bubbles or the pen does not click.

Needles should be changed with every injection, and choosing the right tirzepatide injection needle reduces discomfort and raises the risk of a skin reaction. If you need replacement needles, compatible pen needles are available from our pharmacy. Safe disposal matters too: used needles go into a sharps bin, not household waste, a 1-litre sharps container is the right size for home use. Storage is straightforward between doses: keep the pen refrigerated at 2–8°C, away from the freezer compartment. The exact room-temperature window is in the Patient Information Leaflet that comes with your pen, follow that, not a generic figure you've read online.

The cost context, and what a transparent price actually includes

Private tirzepatide pricing has shifted since Eli Lilly raised its UK list price from 1 September 2025, with the highest-dose pen's list price moving from around £122 to around £330. Typical private market prices since then range roughly £149–£375 per month by dose and provider, as widely reported. That range matters because what a headline price includes varies considerably, some providers charge separately for the consultation, the prescription and delivery. For a fuller breakdown of what drives those figures and what to look for, the Mounjaro UK price change explained page covers the detail.

At nume, one price covers the clinical consultation, the prescription, the medicine and free next-working-day tracked delivery by DPD, no subscriptions, no auto-renewals, and a prescriber reviews every repeat order. We are deliberately not the cheapest option on the market. What that buys you is a GPhC-registered pharmacy (premises number 9012878, verifiable at pharmacyregulation.org), a real clinical review the same day you submit your consultation, and medicine sourced through the licensed UK supply chain. If you would prefer to receive your treatment in person, our page on finding Mounjaro injections near you can help you locate a regulated local provider. When you're ready, you can check your eligibility and start your free consultation, our prescribers aim to review the same day for consultations submitted before midday, Monday to Friday.